Skip to main content
SpringerLink
Log in

Neuroprotektion durch Pharmaka

  • Conference paper
Demenz

  • 120 Accesses

Zusammenfassung

Massive zerebrale Durchblutungsstörungen führen zum Absterben von Nervenzellen. Die Verringerung dieses Schadens ist Ziel einer Therapie mit neuroprotektiven Pharmaka. Trotz unterschiedlicher pharmakologischer Ansätze scheint die Wirkung vieler Substanzen auf den Erhalt der neuronalen Kalziumhomöostase gerichtet zu sein.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bormann J (1989) Memantine as a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166:591–592

    Article  PubMed  CAS  Google Scholar 

  2. Goldberg MP, Weiss JH, Pham PC, Choi DW (1988) N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J Pharmacol Exp Ther 243:784–791

    Google Scholar 

  3. Hall ED, Pazara KE (1989) Effects of novel 21-aminosteroid antioxidants on postishemic neuronal degeneration. In: Ginsberg MD, Dietrich WD (eds) Cerebrovascular diseases. Raven, New York, pp 387–391

    Google Scholar 

  4. Karkoutly C, Seif EL, Nasr M, Peruche B, Ahlemeyer B, Mennel HD, Roßberg C, Krieglstein J (1989) Evaluation of neuroprotective drug effects in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol [Suppl] 339:R107

    Google Scholar 

  5. Kirino T (1982) Delayed neuronal cell death in the gerbil hippocampus following ischemia. Brain Res 239:57–69

    Article  PubMed  CAS  Google Scholar 

  6. Krieglstein J (ed) (1989) Pharmacology of cerebral ischemia 1988. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  7. Krieglstein J (1990) Pharmacology and drug therapy of cerebral ischemia. In: Schurr A, Rigor BM (eds) Cerebral ischemia and resuscitation. CRC Press, Boca Raton, pp 347–371

    Google Scholar 

  8. Murphy SN, Miller RJ (1989) A glutamate receptor regulates Ca2+ mobilization in hippocampal neurons. Proc Natl Acad Sci USA 85:8737–8741

    Article  Google Scholar 

  9. Peroutka S J (1988) 5-Hydroxytryptamine receptor subtypes. Ann Rev Neurosci 11:45–60

    Article  PubMed  CAS  Google Scholar 

  10. Peruche B, Ahlemeyer B, Brungs H, Krieglstein J (1990) Cultured neurons for testing antihypoxic drug effects. J Pharmacol Methods 23:63–77

    Article  PubMed  CAS  Google Scholar 

  11. Pulsinelli W, Brierley JB (1979) A new model of bilateral hemispheric ischemia in the unanaesthetized rat. Stroke 10:267–272

    Article  PubMed  CAS  Google Scholar 

  12. Rothman SM (1984) Synaptic release of excitatory amino acids mediates death of hypo- xic neurons. Science 220:536–537

    Article  Google Scholar 

  13. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247:571–574

    Article  PubMed  CAS  Google Scholar 

  14. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjö BK (1984) Models for studying long-term recovery following forebrain ischemia in the rat. A 2-vessel-occlusion model. Acta Neurol Scand 69:385–401

    Article  PubMed  CAS  Google Scholar 

  15. Siesjö BK (1981) Cell damage in the brain: A speculative synthesis. J Cereb Blood Flow Metabol 1:155–185

    Article  Google Scholar 

  16. Suno M, Terao S, Nagaoka A (1983) Inhibition by vinpocetine (TCV-3B) of lipoperoxide generation from arachidonate. J Tekedfa Res Lab 42:249–252

    CAS  Google Scholar 

  17. Tamura A, Graham DI, McCulloch J, Teasdale GM (1981) Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53–62

    Article  PubMed  CAS  Google Scholar 

  18. Welsch M, Karkoutly C, Nuglisch J, Roßberg C, Mennel HD, Krieglstein J (1990) Nimodipin wirkt neuroprotektiv ohne Steigerung der lokalen zerebralen Durchblutung. PZ Wissenschaft 3/135:29–34

    CAS  Google Scholar 

Download references

Authors
  1. J. Krieglstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Oberpichler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrischen Klinik mit Poliklinik, Universität Erlangen-Nürnberg, Schwabachanlage 6-10, D-8520, Erlangen, Deutschland

    Eberhard Lungershausen (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Krieglstein, J., Oberpichler, H. (1992). Neuroprotektion durch Pharmaka. In: Lungershausen, E. (eds) Demenz. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76932-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76932-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76933-7

  • Online ISBN: 978-3-642-76932-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation